Checkmate Pharmaceuticals Inc (CMPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2001 | 09-2001 | 06-2001 | 03-2001 | 12-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,555 | -2,265 | -482 | -6,778 | -2,596 |
| Depreciation Amortization | 3,088 | 1,993 | 973 | 3,823 | 3,056 |
| Income taxes - deferred | -2,502 | -1,334 | N/A | -4,394 | -1,739 |
| Accounts receivable | 5,007 | 435 | -792 | 8,043 | 6,484 |
| Accounts payable and accrued liabilities | -3,171 | 550 | -401 | -9,311 | -8,502 |
| Other Working Capital | 7,914 | 6,573 | 2,543 | 7,117 | -3,250 |
| Other Operating Activity | -1,402 | -555 | 1,153 | 2,680 | 2,812 |
| Operating Cash Flow | $5,379 | $5,397 | $2,994 | $1,180 | $-3,735 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,117 | -514 | -309 | -5,028 | -4,040 |
| Net Acquisitions | N/A | N/A | N/A | -137 | -137 |
| Investing Cash Flow | $-1,117 | $-514 | $-309 | $-5,165 | $-4,177 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 89,415 | 59,832 | 31,595 | 170,792 | 138,753 |
| Debt Repayment | -94,450 | -64,732 | -34,244 | -165,768 | -129,875 |
| Dividend Paid | N/A | N/A | N/A | -958 | -957 |
| Financing Cash Flow | $-5,035 | $-4,900 | $-2,649 | $4,066 | $7,921 |
| Exchange Rate Effect | -114 | -88 | 59 | -93 | -34 |
| Beginning Cash Position | 1,547 | 1,547 | 1,547 | 1,559 | 1,559 |
| End Cash Position | 660 | 1,442 | 1,642 | 1,547 | 1,534 |
| Net Cash Flow | $-887 | $-105 | $95 | $-12 | $-25 |
| Free Cash Flow | |||||
| Operating Cash Flow | 5,379 | 5,397 | 2,994 | 1,180 | -3,735 |
| Capital Expenditure | -1,117 | -514 | -309 | -5,028 | -4,040 |
| Free Cash Flow | 4,262 | 4,883 | 2,685 | -3,848 | -7,775 |